APA (7th ed.) Citation

Berndt, R., Hummitzsch, L., Heß, K., Albrecht, M., Zitta, K., Rusch, R., . . . Groß, J. (2018). Allogeneic transplantation of programmable cells of monocytic origin (PCMO) improves angiogenesis and tissue recovery in critical limb ischemia (CLI): A translational approach. Stem Cell Research & Therapy, 9(1), N.PAG. https://doi.org/10.1186/s13287-018-0871-8

Chicago Style (17th ed.) Citation

Berndt, Rouven, et al. "Allogeneic Transplantation of Programmable Cells of Monocytic Origin (PCMO) Improves Angiogenesis and Tissue Recovery in Critical Limb Ischemia (CLI): A Translational Approach." Stem Cell Research & Therapy 9, no. 1 (2018): N.PAG. https://doi.org/10.1186/s13287-018-0871-8.

MLA (9th ed.) Citation

Berndt, Rouven, et al. "Allogeneic Transplantation of Programmable Cells of Monocytic Origin (PCMO) Improves Angiogenesis and Tissue Recovery in Critical Limb Ischemia (CLI): A Translational Approach." Stem Cell Research & Therapy, vol. 9, no. 1, 2018, p. N.PAG, https://doi.org/10.1186/s13287-018-0871-8.